Showing results (1431-1440 of 2,693) with videos related to

Sort By:
Pageof 270
The Lancet. Infectious Diseases|October 20, 2023
The African eye worm: current understanding of the epidemiology, clinical disease, and treatment of loiasisMichael Ramharter, Joanna Butler, Ghyslain Mombo-Ngoma, et al.
The Lancet. Infectious Diseases|October 26, 2023
Understanding vancomycin nephrotoxicity augmented by β-lactams: a synthesis of endosymbiosis, proximal renal tubule mitochondrial metabolism, and β-lactam chemistrySara Alosaimy, Michael J Rybak, George Sakoulas
The Lancet. Infectious Diseases|October 2, 2023
Chronic intestinal schistosomiasis caused by co-infection with Schistosoma intercalatum and Schistosoma mansoniPrzemysław Kołodziej, Beata Szostakowska, Anna Lass, et al.
The Lancet. Infectious Diseases|October 1, 2023
Boosting pathogen genomics and bioinformatics workforce in AfricaHarris Onywera, Pascale Ondoa, Faith Nfii, et al.
The Lancet. Infectious Diseases|July 20, 2023
Mpox vaccine and infection-driven human immune signatures: an immunological analysis of an observational studyHallie Cohn, Nathaniel Bloom, Gianna Y Cai, et al.
The Lancet. Infectious Diseases|July 15, 2023
Duration of protection of ancestral-strain monovalent vaccines and effectiveness of bivalent BA.1 boosters against COVID-19 hospitalisation in England: a test-negative case-control studyFreja Cordelia Møller Kirsebom, Nick Andrews, Julia Stowe, et al.
The Lancet. Infectious Diseases|July 16, 2023
Simian malaria: a narrative review on emergence, epidemiology and threat to global malaria eliminationKimberly M Fornace, Gabriel Zorello Laporta, Indra Vythilingham, et al.
The Lancet. Infectious Diseases|July 16, 2023
Mortality associated with third-generation cephalosporin resistance in Enterobacterales bloodstream infections at eight sub-Saharan African hospitals (MBIRA): a prospective cohort studyAlexander M Aiken, Andrea M Rehman, Marlieke E A de Kraker, et al.
The Lancet. Infectious Diseases|July 7, 2023
Safety and immunogenicity of a novel multivalent OspA-based vaccine candidate against Lyme borreliosis: a randomised, phase 1 study in healthy adultsNicole Bézay, Romana Hochreiter, Vera Kadlecek, et al.
The Lancet. Infectious Diseases|July 6, 2023
Causal chemoprophylactic activity of cabamiquine against Plasmodium falciparum in a controlled human malaria infection: a randomised, double-blind, placebo-controlled study in the NetherlandsJohan L van der Plas, Vincent P Kuiper, Wilhelmina M Bagchus, et al.
Pageof 270